WHO clears Bavarian Nordic's vaccine as first shot against mpox

(Reuters) -The World Health Organization said on Friday it had cleared Bavarian Nordic's vaccine as the first shot against mpox.

The approval, known as a pre-qualification, is an official list of medicines used as a benchmark for procurement by developing countries.



"This first prequalification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future," WHO Director-General Dr Tedros Adhanom Ghebreyesus said.

Mpox, a viral infection that spreads through close contact and is usually mild but can kill, was declared a public emergency of international concern by the WHO last month.

Source: Investing.com

Последние публикации
European shares edge higher as traders brace for data-packed week
23.09.2024 - 13:00
Samsung plans to invest $1.8 billion more in Vietnam for OLED manufacturing
23.09.2024 - 13:00
Morgan Stanley moves to neutral on Defensives vs Cyclicals
23.09.2024 - 13:00
Pro Research: Wall Street dives into Regeneron's robust prospects
23.09.2024 - 13:00
Commerzbank lower after German government says no plan to sell any more shares
23.09.2024 - 13:00
Stocks to benefit from slower wage growth, Goldman says
23.09.2024 - 13:00
EM equities saw 10th week of outflows - JPMorgan
23.09.2024 - 13:00
S&P 500 in for a 'bumpy ride, but path should be higher': BTIG
23.09.2024 - 13:00
Hugo Boss falls as profit at UK arm slashed
23.09.2024 - 13:00
Pro Research: Wall Street dives into SolarEdge's market dynamics
23.09.2024 - 12:00
European shares flat ahead of data-packed week
23.09.2024 - 12:00
European stocks mixed; PMIs, Commerzbank in spotlight
23.09.2024 - 12:00
Hedge funds remained net sellers post-Fed, says JPMorgan
23.09.2024 - 12:00
Britain's Rightmove to weigh REA Group's sweetened $8.1 billion takeover bid
23.09.2024 - 12:00
Qualcomm floats Intel takeover - analysts weigh in
23.09.2024 - 12:00

© Analytic DC. All Rights Reserved.

new
Торговые идеи EUR/USD
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.